The present experiments were designed to evaluate in vivo the differential sensitivity of tumor cell subpopulations to hormone and polyamine manipulations using the hormone-responsive N-nitrosomethyl-urea (NMU)-induced rat mammary tumor. NMU tumor bearing rats were randomly assigned to control, ovariectomy, α-difluoromethyl-ornithine (DFMO) administration (an inhibitor of polyamine biosynthesis), or combination treatment, and were sacrificed on day 2, 4, or 7. The proportion of different cells was estimated by morphometric analysis and their replicative activities by [3H]-thymidine autoradiography. In tumors of intact rats, the fractions of glandular, myoepithelial, and non-epithelial cells were 85.3 ± 2.2%, 4.7 ± 0.7%, and 9.9 ± 1.9%, respectively. Ovariectomy induced a similar time-dependent decline in the labelling indices of each cell type (from 5% to 1%). It also decreased the fraction of glandular cells (74.9 ± 4.5%), while increasing the fraction of myoepithelial (8.6 ± 1.9%) and non-epithelial (16.3 ± 3.2%) cells. DFMO exerted similar but more modest effects. DFMO-induced tumor regression was also inferior to that observed with ovariectomy. Combined ovariectomy and DFMO induced a faster and greater suppression of all labelling indices than the individual treatments, even though tumor regression was not superior to that produced by ovariectomy alone. Combination treatment also produced more profound morphologic changes, reducing the fraction of glandular cells to 64.4 ± 3.9% and increasing that of non-epithelial cells to 26.6 ± 4.4%. Ovariectomy and DFMO reduced height but not width of glandular cells, resulting in a modest decrease in cell volume. The combination treatment, however, significantly suppressed all three parameters. Cellular levels of polyamines were only modestly affected by the treatment used, thus raising doubts on their role as mediators, at least of ovariectomy-induced effects. Nevertheless, these results emphasize the sensitivity of different cell components of NMU tumors to combined hormone and anti-polyamine therapy with regard to kinetic and morphometric changes.
All Science Journal Classification (ASJC) codes
- Cancer Research